Analyst firms · Morgan Stanley · SGEN

Morgan Stanley SGEN price target and rating history

Seagen Inc. (SGEN) · Health Care

Morgan Stanley rates Seagen Inc. (SGEN) Overweight with a $170 price target, as of its latest action on Feb 10, 2022. It has published 5 rating actions on SGEN since July 2021, including 1 upgrade and 0 downgrades.

Current rating
Overweight
Price target
$170
Median target, all firms
Too few
Actions on SGEN
5

Morgan Stanley price target on SGEN

$181$174$16720222023202420252026
Morgan Stanley price target on SGEN, each point a stated target, July 2021 to February 2022.

Every Morgan Stanley rating on SGEN

Questions about Morgan Stanley and SGEN

What is Morgan Stanley's price target for SGEN?
Morgan Stanley's latest stated price target for Seagen Inc. (SGEN) is $170, from its action on Feb 10, 2022.
What is Morgan Stanley's rating on SGEN?
Morgan Stanley rates SGEN Overweight, a bullish rating, as of Feb 10, 2022.
When did Morgan Stanley last change its view on SGEN?
On Feb 10, 2022, Morgan Stanley cuts its price target to $170 from $175, keeps Overweight.

More SGEN rating histories

All Morgan Stanley ratingsSGEN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.